Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure
- 1 April 2004
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (8) , 1007-1011
- https://doi.org/10.1016/j.amjcard.2003.12.054
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6Published by Oxford University Press (OUP) ,2000
- Cardiotrophin-1 Increases Angiotensinogen mRNA in Rat Cardiac Myocytes Through STAT3Hypertension, 2000
- The Development of AIDS-Associated Burkitt's/Small Noncleaved Cell Lymphoma Is Preceded by Elevated Serum Levels of Interleukin 6Clinical Immunology, 1999
- Cardiotrophin‐1 (CT‐1): a novel hypertrophic and cardioprotective agentInternational Journal of Experimental Pathology, 1999
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine productionFertility and Sterility, 1998
- Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In VivoAnnual Review of Immunology, 1996
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)Journal of the American College of Cardiology, 1996
- Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerCancer, 1994
- Natural Killer Cell Activity and Progression-Free Survival in Ovarian CancerGynecologic and Obstetric Investigation, 1993
- The hepatic interleukin‐6 receptor Down‐regulation of the interleukin‐6 binding subunit (gp80) by its ligandFEBS Letters, 1992